HKAPI Advocacy Archives

13 十月 23

本會會員參與廣東省藥品醫療器械創新發展論壇

香港科研製藥聯會高級執行董事陳素娟女士，代表本會參與其中一場圓桌討論。

06 十月 23

HKAPI 2023 Policy Address Recommendations Submission

We are pleased that the HKAPI has submitted the 2023 Policy Address Recommendations to the Hong Kong government.

17 五月 23

HKAPI joined the Panel at 3rd ASGH Project Pitching Sessions

We are delighted to announce that our Senior Executive Director, Ms. Sabrina Chan, was invited by the Hong Kong Trade Development Council (HKTDC) to participate in the 3rd Asia Summit on Global Health (ASGH) as one of the panelists for the Project Pitching Sessions.

16 二月 23

HKAPI x HKSTP – How AI is Transforming Drug Discovery and Clinical Trial Design

The "Symposium - How AI is Transforming Drug Discovery and Clinical Trial Design" was a huge success, with drug developers and investors in attendance to learn about the latest AI technologies in drug discovery and clinical development.

11 十一月 22

亞洲醫療健康高峰論壇

香港科研製藥聯會很榮幸，獲邀以醫療健康營商諮詢服務區支持夥伴身份，參與由香港特區政府及香港貿易發展區主辦的「亞洲醫療健康高峰論壇」。

09 十一月 22

2nd CEO Meeting 2022-2024

Dear member, Following the Cheif Executive’s presentation of his first Policy Address on 19 October 2022, the HKAPI is organizing the second CEO meeting of this term (2022 – 2024) […]